Electromed, Inc. Announces CFO Transition
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Mar 4, 2020--
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that CFO Jeremy Brock has elected to pursue other opportunities and the Company and Mr. Brock have established a transition plan. Mr. Brock will continue in the role of CFO until July 1, 2020. Electromed has commenced a national search process to identify and recruit its next CFO.
Kathleen Skarvan, Electromed’s President and CEO, commented, “I would like to thank Jeremy for his leadership and many contributions to Electromed over the past eight years. He helped build a strong financial team and rigorous processes to support the growth of our business. We appreciate his willingness to assist during the CFO transition and know that he will be successful in his next endeavors.”
Mr. Brock added, “It has been rewarding to help build a vibrant business with Kathleen and the team. As a committed shareholder, I look forward to a bright future for Electromed in the years to come.”
About Electromed, Inc.
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest ® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200304005553/en/
CONTACT: Electromed, Inc.
Kathleen Skarvan, President and Chief Executive Officer
email@example.comThe Equity Group Inc.
Kalle Ahl, CFA
KEYWORD: MINNESOTA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: GENERAL HEALTH SURGERY MEDICAL DEVICES HOSPITALS HEALTH
SOURCE: Electromed, Inc.
Copyright Business Wire 2020.
PUB: 03/04/2020 04:30 PM/DISC: 03/04/2020 04:30 PM